Literature DB >> 2360793

Instability of gaze during locomotion in patients with deficient vestibular function.

G E Grossman1, R J Leigh.   

Abstract

We measured the stability of gaze in the horizontal and vertical planes, in 2 patients with bilaterally deficient vestibular function while they sat, stood still, walked in place, and made active horizontal and vertical head rotations. During sitting and standing, gaze was equally as stable as that in normal subjects. During walking in place, however, gaze velocity was double that of normal subjects. Thus, our patients' complaints of impaired vision and oscillopsia during walking could be ascribed to excessive motion of images on their retinas. Eye movements compensated for head rotations more effectively (higher gain) during active head rotations than during locomotion; this difference may be due to the predictable nature of active head movements. We conclude that testing of patients with vestibular symptoms should include stimuli corresponding to the rotational head perturbations that occur during locomotion; such head rotations have nonpredictable characteristics and a frequency range of 0.5 to 5.0 Hz.

Entities:  

Mesh:

Year:  1990        PMID: 2360793     DOI: 10.1002/ana.410270512

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  23 in total

1.  New portable tool to screen vestibular and visual function--National Institutes of Health Toolbox initiative.

Authors:  Rose Marie Rine; Dale Roberts; Bree A Corbin; Roberta McKean-Cowdin; Rohit Varma; Jennifer Beaumont; Jerry Slotkin; Michael C Schubert
Journal:  J Rehabil Res Dev       Date:  2012

2.  A multichannel semicircular canal neural prosthesis using electrical stimulation to restore 3-d vestibular sensation.

Authors:  Charles C Della Santina; Americo A Migliaccio; Amit H Patel
Journal:  IEEE Trans Biomed Eng       Date:  2007-06       Impact factor: 4.538

3.  Bilateral labyrinthectomy in the cat: motor behaviour and quiet stance parameters.

Authors:  D B Thomson; J T Inglis; R H Schor; J M Macpherson
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

Review 4.  Selected ENT symptoms in functional disorders of the upper cervical spine and temporomandibular joints.

Authors:  M Hölzl; R Behrmann; E Biesinger; W von Heymann; R Hülse; U R Goessler; C Arens
Journal:  HNO       Date:  2019-03       Impact factor: 1.284

5.  Eye Movements Are Correctly Timed During Walking Despite Bilateral Vestibular Hypofunction.

Authors:  Eric R Anson; Tim Kiemel; John P Carey; John J Jeka
Journal:  J Assoc Res Otolaryngol       Date:  2017-06-07

6.  [Selected otorhinolaryngological symptoms in functional disorders of the upper cervical spine and temporomandibular joints].

Authors:  M Hölzl; R Behrmann; E Biesinger; W von Heymann; R Hülse; C Arens
Journal:  HNO       Date:  2018-03       Impact factor: 1.284

Review 7.  Vestibular, locomotor, and vestibulo-autonomic research: 50 years of collaboration with Bernard Cohen.

Authors:  Theodore Raphan
Journal:  J Neurophysiol       Date:  2019-11-20       Impact factor: 2.714

8.  The influence of age and vestibular disorders on gaze stabilization: a pilot study.

Authors:  Miranda R Pritcher; Susan L Whitney; Gregory F Marchetti; Joseph M Furman
Journal:  Otol Neurotol       Date:  2008-10       Impact factor: 2.311

9.  Vestibular function assessment using the NIH Toolbox.

Authors:  Rosemarie M Rine; Michael C Schubert; Susan L Whitney; Dale Roberts; Mark S Redfern; Mark C Musolino; Jennica L Roche; Daniel P Steed; Bree Corbin; Chia-Cheng Lin; Greg F Marchetti; Jennifer Beaumont; John P Carey; Neil P Shepard; Gary P Jacobson; Diane M Wrisley; Howard J Hoffman; Gabriel Furman; Jerry Slotkin
Journal:  Neurology       Date:  2013-03-12       Impact factor: 9.910

10.  Age-Related Imbalance Is Associated With Slower Walking Speed: An Analysis From the National Health and Nutrition Examination Survey.

Authors:  Yanjun J Xie; Elizabeth Y Liu; Eric R Anson; Yuri Agrawal
Journal:  J Geriatr Phys Ther       Date:  2017 Oct/Dec       Impact factor: 3.381

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.